Age 0 3 0 3 B-age
14 4 6 4 6 B-lower_bound
- 7 8 7 8 O
21 9 11 9 11 B-upper_bound
years 12 17 12 17 I-upper_bound

Allergy 0 7 18 25 O
or 8 10 26 28 O
intolerance 11 22 29 40 O
to 23 25 41 43 O
N 26 27 44 45 B-allergy_name
- 27 28 45 46 I-allergy_name
acetylcysteine 28 42 46 60 I-allergy_name

Current 0 7 61 68 O
use 8 11 69 72 O
of 12 14 73 75 O
N 15 16 76 77 B-treatment
- 16 17 77 78 I-treatment
acetylcysteine 17 31 78 92 I-treatment
or 32 34 93 95 O
any 35 38 96 99 O
supplement 39 49 100 110 O
containing 50 60 111 121 O
N 61 62 122 123 O
- 62 63 123 124 O
acetylcysteine 63 77 124 138 O
( 78 79 139 140 O
must 79 83 140 144 O
agree 84 89 145 150 O
not 90 93 151 154 O
to 94 96 155 157 O
take 97 101 158 162 O
any 102 105 163 166 O
such 106 110 167 171 O
supplement 111 121 172 182 O
throughout 122 132 183 193 O
study 133 138 194 199 O
participation 139 152 200 213 O
) 152 153 213 214 O

Females 0 7 215 222 B-gender
must 8 12 223 227 O
agree 13 18 228 233 B-contraception_consent
to 19 21 234 236 I-contraception_consent
use 22 25 237 240 I-contraception_consent
appropriate 26 37 241 252 I-contraception_consent
birth 38 43 253 258 I-contraception_consent
control 44 51 259 266 I-contraception_consent
methods 52 59 267 274 I-contraception_consent
during 60 66 275 281 O
study 67 72 282 287 O
participation 73 86 288 301 O
: 86 87 301 302 O
oral 88 92 303 307 B-contraception_consent
contraceptives 93 107 308 322 I-contraception_consent
, 107 108 322 323 O
contraceptive 109 122 324 337 B-contraception_consent
patch 123 128 338 343 I-contraception_consent
, 128 129 343 344 O
barrier 130 137 345 352 B-contraception_consent
( 138 139 353 354 I-contraception_consent
diaphragm 139 148 354 363 I-contraception_consent
or 149 151 364 366 I-contraception_consent
condom 152 158 367 373 I-contraception_consent
) 158 159 373 374 I-contraception_consent
, 159 160 374 375 O
levonorgestrel 161 175 376 390 B-contraception_consent
implant 176 183 391 398 I-contraception_consent
, 183 184 398 399 O
medroxyprogesterone 185 204 400 419 B-contraception_consent
acetate 205 212 420 427 I-contraception_consent
, 212 213 427 428 O
complete 214 222 429 437 B-contraception_consent
abstinence 223 233 438 448 I-contraception_consent
from 234 238 449 453 I-contraception_consent
sexual 239 245 454 460 I-contraception_consent
intercourse 246 257 461 472 I-contraception_consent
, 257 258 472 473 O
or 259 261 474 476 O
hormonal 262 270 477 485 B-contraception_consent
contraceptive 271 284 486 499 I-contraception_consent
vaginal 285 292 500 507 I-contraception_consent
ring 293 297 508 512 I-contraception_consent

Females 0 7 513 520 B-gender
who 8 11 521 524 O
are 12 15 525 528 O
pregnant 16 24 529 537 B-pregnancy
or 25 27 538 540 O
lactating 28 37 541 550 O

Must 0 4 551 555 O
meet 5 9 556 560 O
current 10 17 561 568 O
( 18 19 569 570 O
within 19 25 570 576 O
last 26 30 577 581 B-upper_bound
30 31 33 582 584 I-upper_bound
days 34 38 585 589 I-upper_bound
) 38 39 589 590 O
DSM-5 40 45 591 596 O
criteria 46 54 597 605 O
for 55 58 606 609 O
cannabis 59 67 610 618 B-chronic_disease
use 68 71 619 622 I-chronic_disease
disorder 72 80 623 631 I-chronic_disease

Use 0 3 632 635 O
of 4 6 636 638 O
carbamazepine 7 20 639 652 B-treatment
or 21 23 653 655 O
nitroglycerin 24 37 656 669 B-treatment
within 38 44 670 676 O
14 45 47 677 679 B-upper_bound
days 48 52 680 684 I-upper_bound
of 53 55 685 687 O
randomization 56 69 688 701 O
or 70 72 702 704 O
expectation 73 84 705 716 O
of 85 87 717 719 O
future 88 94 720 726 O
use 95 98 727 730 O
during 99 105 731 737 O
protocol 106 114 738 746 O
participation 115 128 747 760 O

under 0 5 761 766 O
18 6 8 767 769 B-upper_bound
years 9 14 770 775 I-upper_bound
old 15 18 776 779 B-age

